Alexandria New Medical Center engages in the operation of a hospital in Egypt.
Price History & Performance
|Historical stock prices|
|Current Share Price||ج.م54.54|
|52 Week High||ج.م22.08|
|52 Week Low||ج.م65.31|
|1 Month Change||0%|
|3 Month Change||-5.53%|
|1 Year Change||65.87%|
|3 Year Change||235.36%|
|5 Year Change||213.25%|
|Change since IPO||1,664.24%|
Recent News & Updates
|AMES||EG Healthcare||EG Market|
Return vs Industry: AMES exceeded the EG Healthcare industry which returned -14.9% over the past year.
Return vs Market: AMES exceeded the EG Market which returned 11.1% over the past year.
Stable Share Price: AMES is less volatile than 75% of EG stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: AMES's weekly volatility (2%) has been stable over the past year.
About the Company
Alexandria New Medical Center engages in the operation of a hospital in Egypt. The company’s hospital provides range of medical specialization services, including gynecology, general surgery, pediatrics, and other, as well as medical diagnostic and treatment services in various medical fields. It also operates children’s, brain and nerve disease, sugar, liver, chest, cardiology, internal, oncology, dental, nose and ear, women’s, ophthalmology, nutrition, dermatology, blood disease, and rheumatology clinics; specialized units and centers; and dormitories.
Alexandria New Medical Center Fundamentals Summary
|AMES fundamental statistics|
Is AMES overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|AMES income statement (TTM)|
|Cost of Revenue||ج.م151.91m|
Last Reported Earnings
Mar 31, 2021
Next Earnings Date
|Earnings per share (EPS)||1.69|
|Net Profit Margin||11.16%|
How did AMES perform over the long term?See historical performance and comparison
Is Alexandria New Medical Center undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: AMES (EGP54.54) is trading above our estimate of fair value (EGP15.19)
Significantly Below Fair Value: AMES is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: AMES's PE Ratio (32.3x) is in line with the African Healthcare industry average.
PE vs Market: AMES is poor value based on its PE Ratio (32.3x) compared to the EG market (11.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AMES's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: AMES is overvalued based on its PB Ratio (3.6x) compared to the XF Healthcare industry average (2.8x).
How is Alexandria New Medical Center forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Alexandria New Medical Center has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Alexandria New Medical Center performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AMES has high quality earnings.
Growing Profit Margin: AMES's current net profit margins (11.2%) are higher than last year (10.6%).
Past Earnings Growth Analysis
Earnings Trend: AMES's earnings have grown by 11.1% per year over the past 5 years.
Accelerating Growth: AMES's earnings growth over the past year (13.7%) exceeds its 5-year average (11.1% per year).
Earnings vs Industry: AMES earnings growth over the past year (13.7%) exceeded the Healthcare industry 4.5%.
Return on Equity
High ROE: AMES's Return on Equity (11.9%) is considered low.
How is Alexandria New Medical Center's financial position?
Financial Position Analysis
Short Term Liabilities: AMES's short term assets (EGP170.6M) exceed its short term liabilities (EGP83.2M).
Long Term Liabilities: AMES's short term assets (EGP170.6M) exceed its long term liabilities (EGP8.1M).
Debt to Equity History and Analysis
Debt Level: AMES's debt to equity ratio (14.9%) is considered satisfactory.
Reducing Debt: AMES's debt to equity ratio has reduced from 19.3% to 14.9% over the past 5 years.
Debt Coverage: AMES's debt is well covered by operating cash flow (98%).
Interest Coverage: AMES's interest payments on its debt are well covered by EBIT (15.9x coverage).
What is Alexandria New Medical Center current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AMES's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AMES's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AMES's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AMES's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AMES's dividend in 3 years as they are not forecast to pay a notable one for the EG market.
How experienced are the management team and are they aligned to shareholders interests?
Bavaguthu Shetty (78 yo)
Dr. Bavaguthu Raghuram Shetty is the Founder and Chief Executive Officer at BR Healthcare Suites. Dr. Shetty is the Founding Partner, Chief Executive Officer and Managing Director at New Medical Centre Hos...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Alexandria New Medical Center's employee growth, exchange listings and data sources
- Name: Alexandria New Medical Center
- Ticker: AMES
- Exchange: CASE
- Founded: 1988
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: ج.م849.335m
- Shares outstanding: 15.57m
- Website: https://www.anmchosp.com
- Alexandria New Medical Center
- May 14 Road
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/22 14:31|
|End of Day Share Price||2021/10/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.